i
n
f
l
a
r
x
Loading
About Inflarx
Leadership Team
Board of Directors
Company History
R & D
Pipeline
Vilobelimab
INF904
IFX002
Complement Platform
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Shareholder Meetings
Email alerts
Careers
The InflaRx Commitment
About Inflarx
Leadership Team
Board of Directors
Company History
R & D
Pipeline
Vilobelimab
INF904
IFX002
Complement Platform
Clinical Development
Pyoderma Gangraenosum
COVID-19
Clinical Trials
Publications & Posters
Investors
Press Releases
Events
Financial Information
Share Information
Analyst Coverage
Corporate Governance
Shareholder Meetings
Email alerts
Careers
The InflaRx Commitment
Event - Presentation
Home
Investors
Events
Event - Presentation
World Antimicrobial Resistance Congress
September 7-8, 2023, Philadelphia, PA, USA
Panel discussion, September 7, 11:20 am EDT with Prof. Niels C. Riedemann, CEO
read more
Back